HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: gut.2006.115725v1 56/10/1433    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Király, O. Articles by Sahin-Tóth, M. Search for Related Content PubMed PubMed Citation Articles by Király, O. Articles by Sahin-Tóth, M.

Missense mutations in pancreatic secretory trypsin inhibitor (SPINK1) cause intracellular retention and degradation

¹ Department of Molecular and Cell Biology, Boston University, Goldman School of Dental Medicine, Boston, MA, USA
² Division of Experimental Surgery; Department of Surgery, Otto-von-Guericke University, Magdeburg, Germany

Correspondence to:
Correspondence to:
Miklós Sahin-Tóth
715 Albany Street, Evans-433; Boston, MA 02118, USA; miklos{at}bu.edu

Background/aims: Mutations of the SPINK1 gene encoding pancreatic secretory trypsin inhibitor have been identified in association with chronic pancreatitis. The vast majority of patients carry the N34S variant, whereas other genetic variants are relatively rare and their disease association is uncertain. The aim of this study was to characterise and compare the functional defects caused by the six published missense mutations that affect mature SPINK1—namely, N34S, D50E, Y54H, P55S, R65Q, and R67C.

Methods: Wild type and mutant SPINK1 were expressed in human embryonic kidney 293T cells via transient transfection. SPINK1 expression was characterised by RT-PCR, activity assays, and western blots.

Results: Mutations N34S and P55S did not alter secretion of SPINK1 from HEK 293T cells, whereas mutation R65Q decreased secretion about twofold. Remarkably, mutations D50E, Y54H, and R67C abolished or markedly diminished secretion, but all three mutants were detected in cell extracts, indicating intracellular retention and degradation.

Conclusions: The results identify intracellular folding defects as a novel mechanism of SPINK1 deficiency associated with chronic pancreatitis. The dramatic effects of the D50E and Y54H mutations indicate that the interaction between Asp50 and Tyr54 is critical for proper folding of the inhibitor. The disease-causing biochemical defect in the N34S mutant is unrelated to secretion or trypsin inhibitory activity and remains enigmatic. Finally, the patent functional defects in mutants D50E, Y54H, and R67C suggest disease association of these rare SPINK variants.

Abbreviations: GAPD, glyceraldehyde-3-phosphate dehydrogenase; HEK, human embryonic kidney; HRP, horseradish peroxidase; K, equilibrium constant; PCR, polymerase chain reaction; RT-PCR, reverse transcriptase polymerase chain reaction; SPINK, serine protease inhibitor, Kazal type 1

Keywords: pancreatitis; protein misfolding; protein folding disease